title: Nebulized morphine in the palliation of dyspnoea.
abstract: Seventeen terminally ill cancer patients with primary or secondary intrathoracic malignancy complaining of breathlessness were treated with nebulized morphine in doses of 20 mg 4-hourly for 48 h. The effect on dyspnoea was evaluated using the Dyspnoea Assessment Questionnaire. Most patients felt less dyspnoeic after 24 h; the effect was maintained, but not improved upon, after 48 h.
authors.affiliation: St Joseph's Hospice, Hackney, London, UK.
authors.forename: G
authors.initials: G
authors.lastname: Zeppetella
mesh_terms: D000280:Administration, Inhalation; D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D000701:Analgesics, Opioid / Q000008:administration & dosage*; D004334:Drug Administration Schedule; D004417:Dyspnea / Q000188:drug therapy* / Q000209:etiology; D005260:Female; D006801:Humans; D008175:Lung Neoplasms / Q000150:complications*; D008297:Male; D008875:Middle Aged; D009020:Morphine / Q000008:administration & dosage*; D010166:Palliative Care / Q000379:methods*; D011446:Prospective Studies; D012720:Severity of Illness Index
chemical_list: D000701:Analgesics, Opioid; D009020:Morphine